iForumRx.org

Top Ten Things Every Clinician Should Know About Treating Obesity

Obesity is a chronic, progressive, multi-factorial, neurobehavioral disease characterized by excessive adipose tissue.  Here are some things every clinician should know about treating overweight and obesity but be sure to read the written commentary posted on iForumRx.org

Guest Authors:  Jennifer N. Clements, PharmD, BCPS, BCACP, CDCES, BC-ADM and Seena L. Haines, PharmD., BCACP, NBC-HWC, CHWC

Music by Good Talk

Managing RAAS-Inhibitor-Associated Hyperkalemia in Patients with CKD – A Balancing Act

Hyperkalemia is a common electrolyte disorder in patients with CKD that can be exacerbated by renin-angiotensin-aldosterone system (RAAS) inhibitors. While hyperkalemia poses potential risks to patients with CKD, the potentially negative impact of discontinuing RAAS inhibitor therapy on long-term renal and cardiovascular outcomes in CKD patients is unclear.

Guest Author: Michelle A. Fravel, PharmD, BCPS

Music by Good Talk

Complex Patient Case - Women’s Health + Contraception

Reason for Visit: JS was referred by her PCP to the ambulatory care pharmacist for contraceptive counseling.

Chief Complaint: “I think I’m leaning more towards the pill, but I’m really open to anything. It’s also itchy again down there, probably another yeast infection.”

Guest Author:  Elizabeth Salisbury, PharmD

Expert Panelists:  Ashley Meredith, PharmD, MPH, BCACP; Rebecca Stone, PharmD, BCACP, and Sally Rafie, PharmD, BCPS

 

Wanna earn continuing pharmacy education (CPE) for this program?  Be sure to log-in to the iForumRx website, review the case, listen to the podcast, and scroll to the bottom of the page to claim CE.

 

Check out the Birth Control Pharmacist website.

--------

Top Ten Podcasts Every Ambulatory Care Clinician Should Know About

What is the secret to staying up to date with clinical updates, tips for flourishing in your practice and life, and inspirational stories about pharmacist entrepreneurs…all at the click of a button? No, it is not magic. It is a podcast!

Guest Authors: Elizabeth Yett, PharmD, BCACP, TTS and Elizabeth Hearn, PharmD, BCACP

Music by Good Talk

The Generic Levothyroxine Conundrum

Would you be willing to pay three times more for a brand-name levothyroxine product than a generic equivalent? Clinical practice guidelines recommend against switching between products. As a result, levothyroxine has higher brand-name product dispensing rates than other medications, costing patients and the healthcare system much more money.

Guest Authors:  Connie Liang, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP

Music by Good Talk

Is Icosapent Ethyl a QALY-ty Investment?

The landmark REDUCE-IT trial demonstrated that icosapent ethyl (IPE) 4 g daily significantly reduced cardiovascular events in high-risk patients when added to statin therapy, but is a fancy fish oil supplement really worth our coin?

Guest Authors:  Joseph Nardolillo, PharmD, BCACP and Vivian Cheng, PharmD, BCPS, BCACP

Music by Good Talk

Level Up! An Abstinence Game for Smoking Cessation

Smoking remains a habit for many people, even among those who are motivated to quit. Historically, most smoking cessation interventions have targeted individuals who are ready to quit smoking in the next 30 days, overlooking those who are not yet ready to quit.  Perhaps an abstinence game, Take a Break, can move people in pre-contemplation and contemplation toward quitting.

Guest Authors:  Anna Rhett, PharmD and Ha K. Pham, PharmD, BCACP

Music by Good Talk

Breaking the SABA-only Rescue Habit: Two Drugs Are Better Than One

It is well established that overuse of short-acting beta-agonists (SABA) increases the risk of poor asthma control, exacerbations, and increased mortality.  Several studies have combined a beta-agonist with an inhaled corticosteroid (ICS). The combination provides symptom relief and decreases the risk of poor outcomes.  The days of using albuterol monotherapy should be coming to an end; two drugs are better than one!

Guest Authors:  Katherine Montag Schafer, PharmD, BCACP, CDCES and Stefanie C. Nigro, PharmD, BCACP, CDCES

Music by Good Talk

Are You Sure? Tolerance of Uncertainty and the Risk of Stress-Related Harm

Health professionals must deal with a lot of uncertainty in their work, such as weighing the risks and benefits of various treatment options, determining whether a patient’s symptoms are an adverse effect of medication therapy, or deciding if adding a new drug to the formulary will be cost-effective. A lower tolerance of uncertainty increases the risk of burnout and other stress-related harms. A new study sheds light on several contextual factors that contribute to low tolerance of uncertainty and some potential opportunities for intervention.

Guest Author: Brent Reed, PharmD, MS, BCCP

Music by Good Talk

Top Ten Things Every Clinician Should Know About the 2022 Heart Failure Guidelines

The 2022 AHA/ACC/HFSA Heart Failure Guidelines is a much-needed update and consolidates previously published recommendations. In the written commentary we describe the top ten things every clinician should know about the 2022 AHA/ACC/HFSA Heart Failure Guidelines.  This podcast episode highlights some of the key recommendations from the guidelines and addresses some of the practical implications.

Guest Authors:  Madison Yates, PharmD and Megan Supple, PharmD, BCACP, CPP

Music by Good Talk